- Else Nutrition (BABY) has announced revenue growth at the high end of its Q1 2022 expectations
- Else anticipates continued revenue growth in Q2 with revenues between C$1.8M and C$2.0M
- Revenues on Amazon.com increased by 40 per cent QoQ
- Else Nutrition G.H. Ltd. is an Israel-based food and nutrition company focused on developing plant-based food and nutrition products for infants, toddlers, children, and adults
- Else (BABY) opened trading at C$1.36 per share
Else Nutrition (BABY) has announced revenue growth at the high end of its Q1 2022 expectations.
On March 31st, 2022, the company released its 2021 annual results and expectations for Q1 revenues to be in the range of C$1.45M to C$1.6M. The company expects to be at the top end of this guidance range.
Else anticipates continued revenue growth in Q2 with revenues between C$1.8M and C$2.0M. This increase is driven by the successful launch of Else Toddler Omega and the launch of the Else Super Cereal product line.
Revenues on Amazon.com increased by 40 per cent in Q1 2022 compared with Q4 2021. Else expects to continue at a similar growth rate in Q2, reaching a quarterly revenue run rate of C$1 million. The number of Else subscribers on Amazon.com crossed the 1,000 mark in early April.
“We are delighted to witness our accelerated sales growth,” said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. “With the new super cereal product line and our upcoming launches in Canada, China and Europe, we expect sales to continue accelerating in the coming months.”
Else Nutrition G.H. Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults.
Else (BABY) opened trading at C$1.36 per share.
